CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions |
Total |
Cumulative Effect, Period of Adoption, Adjustment |
Common Stock |
Additional Paid-in Capital |
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
|
Retained Earnings |
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
|
Accumulated Other Comprehensive Loss |
Treasury Stock |
| Balance at beginning of period (in shares) at Dec. 31, 2021 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at beginning of period at Dec. 31, 2021 |
$ 3,682.9
|
$ (44.7)
|
$ 1.9
|
$ 3,051.6
|
$ (57.1)
|
$ 682.2
|
$ 12.4
|
$ (27.3)
|
$ (25.5)
|
| Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
1.0
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Acquisition of treasury stock (in shares) |
|
|
|
|
|
|
|
|
(1.5)
|
| Acquisition of treasury stock |
(34.2)
|
|
|
|
|
|
|
|
$ (34.2)
|
| Compensatory awards released from restriction (in shares) |
|
|
|
|
|
|
|
|
1.0
|
| Compensatory awards released from restriction |
0.0
|
|
|
(24.0)
|
|
|
|
|
$ 24.0
|
| Share-based compensation |
13.8
|
|
|
13.8
|
|
|
|
|
|
| Equity adjustment from foreign currency translation |
(13.4)
|
|
|
|
|
|
|
(13.4)
|
|
| Change in fair value of derivative instruments, net of tax |
9.4
|
|
|
|
|
|
|
9.4
|
|
| Net income (loss) |
86.7
|
|
|
|
|
86.7
|
|
|
|
| Balance at end of period (in shares) at Mar. 31, 2022 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at end of period at Mar. 31, 2022 |
3,700.5
|
|
$ 1.9
|
2,984.3
|
|
781.3
|
|
(31.3)
|
$ (35.7)
|
| Treasury stock, balance at end of period (in shares) at Mar. 31, 2022 |
|
|
|
|
|
|
|
|
1.5
|
| Balance at beginning of period (in shares) at Dec. 31, 2021 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at beginning of period at Dec. 31, 2021 |
3,682.9
|
$ (44.7)
|
$ 1.9
|
3,051.6
|
$ (57.1)
|
682.2
|
$ 12.4
|
(27.3)
|
$ (25.5)
|
| Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
1.0
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income (loss) |
230.6
|
|
|
|
|
|
|
|
|
| Balance at end of period (in shares) at Sep. 30, 2022 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at end of period at Sep. 30, 2022 |
3,806.5
|
|
$ 1.9
|
3,004.2
|
|
925.2
|
|
(92.6)
|
$ (32.2)
|
| Treasury stock, balance at end of period (in shares) at Sep. 30, 2022 |
|
|
|
|
|
|
|
|
(1.3)
|
| Balance at beginning of period (in shares) at Mar. 31, 2022 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at beginning of period at Mar. 31, 2022 |
3,700.5
|
|
$ 1.9
|
2,984.3
|
|
781.3
|
|
(31.3)
|
$ (35.7)
|
| Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2022 |
|
|
|
|
|
|
|
|
1.5
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Acquisition of treasury stock |
(0.3)
|
|
|
0.2
|
|
|
|
|
$ (0.5)
|
| Exercise of stock options |
0.1
|
|
|
(0.2)
|
|
|
|
|
$ 0.3
|
| Compensatory awards released from restriction (in shares) |
|
|
|
|
|
|
|
|
0.1
|
| Compensatory awards released from restriction |
0.0
|
|
|
(1.8)
|
|
|
|
|
$ 1.8
|
| Share-based compensation |
13.2
|
|
|
13.2
|
|
|
|
|
|
| Equity adjustment from foreign currency translation |
(33.2)
|
|
|
|
|
|
|
(33.2)
|
|
| Change in fair value of derivative instruments, net of tax |
4.5
|
|
|
|
|
|
|
4.5
|
|
| Net income (loss) |
105.4
|
|
|
|
|
105.4
|
|
|
|
| Balance at end of period (in shares) at Jun. 30, 2022 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at end of period at Jun. 30, 2022 |
3,790.2
|
|
$ 1.9
|
2,995.7
|
|
886.7
|
|
(60.0)
|
$ (34.1)
|
| Treasury stock, balance at end of period (in shares) at Jun. 30, 2022 |
|
|
|
|
|
|
|
|
1.4
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Acquisition of treasury stock |
(1.0)
|
|
|
|
|
|
|
|
$ (1.0)
|
| Exercise of stock options |
0.5
|
|
|
(0.3)
|
|
|
|
|
$ 0.8
|
| Compensatory awards released from restriction (in shares) |
|
|
|
|
|
|
|
|
0.1
|
| Compensatory awards released from restriction |
0.0
|
|
|
(2.2)
|
|
|
|
|
$ 2.2
|
| Share-based compensation |
10.4
|
|
|
10.4
|
|
|
|
|
|
| Equity adjustment from foreign currency translation |
(38.0)
|
|
|
|
|
|
|
(38.0)
|
|
| Change in fair value of derivative instruments, net of tax |
5.4
|
|
|
|
|
|
|
5.4
|
|
| Issuance of common stock related to convertible notes |
0.5
|
|
|
0.5
|
|
|
|
|
|
| Capped call transaction related to convertible note conversion |
0.0
|
|
|
0.1
|
|
|
|
|
(0.1)
|
| Net income (loss) |
38.5
|
|
|
|
|
38.5
|
|
|
|
| Balance at end of period (in shares) at Sep. 30, 2022 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at end of period at Sep. 30, 2022 |
3,806.5
|
|
$ 1.9
|
3,004.2
|
|
925.2
|
|
(92.6)
|
$ (32.2)
|
| Treasury stock, balance at end of period (in shares) at Sep. 30, 2022 |
|
|
|
|
|
|
|
|
(1.3)
|
| Balance at beginning of period (in shares) at Dec. 31, 2022 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at beginning of period at Dec. 31, 2022 |
$ 3,774.3
|
|
$ 1.9
|
3,012.7
|
|
852.5
|
|
(61.5)
|
$ (31.3)
|
| Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2022 |
1.3
|
|
|
|
|
|
|
|
(1.3)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Acquisition of treasury stock (in shares) |
|
|
|
|
|
|
|
|
(0.4)
|
| Acquisition of treasury stock |
$ (9.2)
|
|
|
|
|
|
|
|
$ (9.2)
|
| Exercise of stock options (in shares) |
|
|
|
|
|
|
|
|
0.2
|
| Exercise of stock options |
3.6
|
|
|
(1.2)
|
|
|
|
|
$ 4.8
|
| Compensatory awards released from restriction (in shares) |
|
|
|
|
|
|
|
|
0.9
|
| Compensatory awards released from restriction |
0.0
|
|
|
(21.3)
|
|
|
|
|
$ 21.3
|
| Share-based compensation |
12.4
|
|
|
12.4
|
|
|
|
|
|
| Equity adjustment from foreign currency translation |
5.3
|
|
|
|
|
|
|
5.3
|
|
| Change in fair value of derivative instruments, net of tax |
(0.3)
|
|
|
|
|
|
|
(0.3)
|
|
| Net income (loss) |
25.0
|
|
|
|
|
25.0
|
|
|
|
| Balance at end of period (in shares) at Mar. 31, 2023 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at end of period at Mar. 31, 2023 |
3,811.1
|
|
$ 1.9
|
3,002.6
|
|
877.5
|
|
(56.5)
|
$ (14.4)
|
| Treasury stock, balance at end of period (in shares) at Mar. 31, 2023 |
|
|
|
|
|
|
|
|
(0.6)
|
| Balance at beginning of period (in shares) at Dec. 31, 2022 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at beginning of period at Dec. 31, 2022 |
$ 3,774.3
|
|
$ 1.9
|
3,012.7
|
|
852.5
|
|
(61.5)
|
$ (31.3)
|
| Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2022 |
1.3
|
|
|
|
|
|
|
|
(1.3)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Net income (loss) |
$ 172.1
|
|
|
|
|
|
|
|
|
| Balance at end of period (in shares) at Sep. 30, 2023 |
|
|
187.0
|
|
|
|
|
|
|
| Balance at end of period at Sep. 30, 2023 |
$ 3,951.9
|
|
$ 1.9
|
3,025.0
|
|
1,024.6
|
|
(54.3)
|
$ (45.3)
|
| Treasury stock, balance at end of period (in shares) at Sep. 30, 2023 |
2.4
|
|
|
|
|
|
|
|
(2.4)
|
| Balance at beginning of period (in shares) at Mar. 31, 2023 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at beginning of period at Mar. 31, 2023 |
$ 3,811.1
|
|
$ 1.9
|
3,002.6
|
|
877.5
|
|
(56.5)
|
$ (14.4)
|
| Treasury stock, balance at beginning of period (in shares) at Mar. 31, 2023 |
|
|
|
|
|
|
|
|
(0.6)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Acquisition of treasury stock (in shares) |
|
|
|
|
|
|
|
|
(1.0)
|
| Acquisition of treasury stock |
(18.1)
|
|
|
|
|
|
|
|
$ (18.1)
|
| Exercise of stock options |
0.1
|
|
|
(0.4)
|
|
|
|
|
$ 0.5
|
| Compensatory awards released from restriction (in shares) |
|
|
|
|
|
|
|
|
0.1
|
| Compensatory awards released from restriction |
0.0
|
|
|
(2.4)
|
|
|
|
|
$ 2.4
|
| Share-based compensation |
12.4
|
|
|
12.4
|
|
|
|
|
|
| Equity adjustment from foreign currency translation |
(1.7)
|
|
|
|
|
|
|
(1.7)
|
|
| Change in fair value of derivative instruments, net of tax |
11.5
|
|
|
|
|
|
|
11.5
|
|
| Net income (loss) |
117.4
|
|
|
|
|
117.4
|
|
|
|
| Balance at end of period (in shares) at Jun. 30, 2023 |
|
|
186.2
|
|
|
|
|
|
|
| Balance at end of period at Jun. 30, 2023 |
3,932.7
|
|
$ 1.9
|
3,012.2
|
|
994.9
|
|
(46.7)
|
$ (29.6)
|
| Treasury stock, balance at end of period (in shares) at Jun. 30, 2023 |
|
|
|
|
|
|
|
|
(1.5)
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
| Acquisition of treasury stock (in shares) |
|
|
|
|
|
|
|
|
(1.0)
|
| Acquisition of treasury stock |
$ (16.7)
|
|
|
|
|
|
|
|
$ (16.7)
|
| Issuance of common stock (in shares) |
0.8
|
|
|
|
|
|
|
|
|
| Exercise of stock options |
$ 0.2
|
|
|
(0.2)
|
|
|
|
|
$ 0.4
|
| Compensatory awards released from restriction (in shares) |
|
|
|
|
|
|
|
|
0.1
|
| Compensatory awards released from restriction |
0.0
|
|
|
(0.6)
|
|
|
|
|
$ 0.6
|
| Share-based compensation |
13.6
|
|
|
13.6
|
|
|
|
|
|
| Equity adjustment from foreign currency translation |
(14.4)
|
|
|
|
|
|
|
(14.4)
|
|
| Change in fair value of derivative instruments, net of tax |
6.8
|
|
|
|
|
|
|
6.8
|
|
| Net income (loss) |
29.7
|
|
|
|
|
29.7
|
|
|
|
| Balance at end of period (in shares) at Sep. 30, 2023 |
|
|
187.0
|
|
|
|
|
|
|
| Balance at end of period at Sep. 30, 2023 |
$ 3,951.9
|
|
$ 1.9
|
$ 3,025.0
|
|
$ 1,024.6
|
|
$ (54.3)
|
$ (45.3)
|
| Treasury stock, balance at end of period (in shares) at Sep. 30, 2023 |
2.4
|
|
|
|
|
|
|
|
(2.4)
|